Enfusion, Inc.
WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
FIGI: BBG012MBFQD7
ENFN
Enfusion, Inc.
GICS: -
·
Sektor: Technology
·
Sub-Sektor: Software - Application
NAME
Enfusion, Inc.
ISIN
US2928121043
TICKER
ENFN
MIC
XNYS
REUTERS
ENFN.N
BLOOMBERG
ENFN US
Financial Intelligence
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Warrants
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Mo., 03.03.2025
Enfusion
US2928121043
Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024.
Fourth Quarter 2024 Financial Highlights:
Total revenue was $52.9 million, up 13.9% compared to the same period in the p...
Enfusion
Di., 25.02.2025
Enfusion
US2928121043
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock is fair to Enfusion shareholders.
Halper Sadeh encourages Enfusion shareholders to click here to learn more about their legal ri...
Enfusion
Di., 14.01.2025
Enfusion
US2928121043
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics Holdings, Inc. (NYSE: CWAN). Under the terms of the proposed transaction, shareholders of Enfusion will receive $5.85 in cash and $5.40 in ...
Enfusion
Mo., 13.01.2025
Enfusion
US2928121043
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Enfusion, Inc. (“Enfusion” or “the Company”) (NYSE: ENFN) for potential breaches of fiduciary duty on the part of its directors and management.
The investigation focuses on determining if the Enfusion board brea...
Enfusion
Mo., 13.01.2025
Enfusion
US2928121043
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock is fair to Enfusion shareholders.
Halper Sadeh encourages Enfusion shareholders to click here to learn more about their legal ri...
Enfusion
Mo., 13.01.2025
Enfusion
US2928121043
Ademi LLP is investigating Enfusion (NYSE: ENFN) for possible breaches of fiduciary duty and other violations of law in its transaction with Clearwater.
Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.
In t...
Enfusion
Mi., 20.11.2024
Enfusion
US2928121043
Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced that Enfusion’s Chief Financial Officer, Brad Herring, and Chief Operating Officer, Neal Pawar, will participate at the following investor events:
Wells Fargo 8th Annual TMT Summit on Tuesday, December ...
Enfusion
Mo., 04.11.2024
Enfusion
US2928121043
Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, has posted its third quarter 2024 financial results as part of its Q3 2024 Shareholder Letter which can be viewed by navigating to the Financials section of its Investor Relations website at http://ir.enfusion.com.
3Q24 ...
Enfusion
Do., 10.10.2024
Enfusion
US2928121043
Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Artuc to Head of Engineering and Jesper Cordes to Head of Client Services Americas. These additions to the leadership team reinforce the company’s position as a global leader in i...
Enfusion
Do., 03.10.2024
Enfusion
US2928121043
Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its third quarter 2024 financial results before the U.S. financial markets open on Monday, November 4, 2024. Management will host a conference call and webcast that same morning at 8:30 AM ...
Enfusion
Informationen zu Product Placements
SMART * AD
P R O D U C T S U G G E S T I O N S
